Global Flow Cytometry Market

Flow Cytometry Market Size, Share, Growth Analysis, By Products(Instruments (Cell Analyzers, Cell Sorters), Reagents & Consumables, Software), By Technology(Cell-based, Bead-based), By Application(Research (Pharmaceutical (Drug Discovery, Stem Cell, In Vitro Toxicity), Apoptosis), By End-Use(Commercial Organizations, Hospitals, Academic Institutes, Clinical Testing Labs), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2031 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 130 | Figures: 77

Flow Cytometry Market News

  • In June 2022, Becton, Dickinson, and Company announced the launch of new cell sorting technology at the International Society for Advancement of Cytometry (ISAC) CYTO 2022 conference. This new technology allows researchers to see and sort cells at speeds never before possible, potentially transforming research and cell-based therapeutic development across a variety of fields, including virology and oncology, as well as a variety of disease states.
  • In August 2021, Becton, Dickinson, and Company introduced the BD FACSymphony A1 Cell Analyzer, a new benchtop cell analyzer. The fluorescence-activated cell analyzer is expected to provide sophisticated flow cytometry capabilities to laboratories of all sizes.
  • In June 2021, The Invitrogen Attune CytPix Flow Cytometer from Thermo Fisher Scientific is an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Flow Cytometry Market was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, at a CAGR of 7.17% over the forecast period (2024-2031).

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players hold a huge share of the market and are likely to remain in a similar competitive environment for the next few years. BD Biosciences is a leader in the flow cytometry market, known for its wide range of flow cytometry devices, reagents and software solutions. The company emphasizes innovation and product development to meet research and clinical needs. 'Becton, Dickinson, and Company (US)', 'Danaher Corporation (US)', 'Thermo Fisher Scientific, Inc. (US)', 'Agilent Technologies, Inc. (US)', 'Sony Group Corporation (Japan)', 'Bio-Rad Laboratories, Inc. (US)', 'Miltenyi Biotec GmbH (Germany)', 'Enzo Biochem, Inc. (US)', 'Sysmex Corporation (Japan)', 'bioMérieux S.A. (France)', 'Cytonome/ ST, LLC (US)', 'Sartorius AG (Germany)', 'Cytek Biosciences, Inc. (US)', 'Union Biometrica, Inc. (US)', 'Fluxion Biosciences, Inc. (US)', 'Apogee Flow Systems Ltd. (UK)', 'Merck KGaA (Germany)', 'Beckman Coulter, Inc. (US)', 'Stratedigm, Inc. (US)', 'Nanocellect Biomedical (US)'

The increasing emphasis on the personalized medicine and targeted therapies is driving the demand for more advanced flow-through methods. The ability of flow cytometry to analyze multiple parameters simultaneously contributes to the accurate characterization of cells, which is crucial for developing personalized treatment plans.

Cell sorting is a pivotal segment of the flow cytometry market, appreciably enhancing the capability to split and analyze individual mobile populations based on specific characteristics. This procedure is essential for the various packages, consisting of cancer research, immunology, and stem mobile research. Advances in cell sorting technology permit researchers and clinicians to isolate rare cell types with high purity and accuracy, facilitating certain studies and personalized medicine procedures. The growing call for specific cellular analysis in both studies and clinical settings is driving the enlargement of this market section.

North America dominated the flow cytometry market. Throughout the forecast period, the region is predicted to dominate the marketplace. This dominance may be attributed to the United States' excessive healthcare spending and the healthcare infrastructure. Furthermore, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies, have created a significant demand for the flow cytometry solutions for research purposes. North America dominated the overall market with 41.20% revenue share in 2023. This can be attributed in large part to the well-established healthcare and pharmaceutical industry in the US, which has driven the demand for flow cytometry solutions great for clinical and research purposes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Flow Cytometry Market

Report ID: SQMIG35H2031

$5,300
BUY NOW GET FREE SAMPLE